Statins may reduce femoral osteolysis in patients with total Hip arthroplasty

Journal of Orthopaedic Research

Volumn 31, Issue 5, 2013, Pages 814-820

  Lübbeke, Anne ^a   Garavaglia, Guido ^a   Rothman, Kenneth J ^b,c   Bonvin, Alexis ^a   Roussos, Constantinos ^a   Miozzari, Hermes ^a   Hoffmeyer, Pierre ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b RTI HEALTH SOLUTIONS   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

osteolysis; statins; total hip arthroplasty

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BONE ATROPHY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEMUR; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TOTAL HIP PROSTHESIS;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; COHORT STUDIES; COMORBIDITY; FEMALE; FEMUR; HIP JOINT; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOLYSIS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; REGISTRIES; RISK FACTORS;

EID: 84875225066     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22262     Document Type: Article

References (33)

1. Kurtz SM, Röder C, Lau E., 2010. International survey of primary and revision total hip replacement. 56th annual meeting of the orthopaedic research society. In: 56th Annual Meeting of the Orthopaedic Research Society New Orleans.
2. Learmonth ID, Young C, Rorabeck C., 2007. The operation of the century: total hip replacement. Lancet 370: 1508-1519.
3. Katz JN., 2006. Total joint replacement in osteoarthritis. Best Pract Res Clin Rheumatol 20: 145-153.
4. Sundfeldt M, Carlsson LV, Johansson CB, et al. 2006. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop 77: 177-197.
5. Annual Report of the Swedish Hip Arthroplasty Register. 2009. Accessed at. http://www.shpr.se/Libraries/Documents/AnnualReport-2009-EN.sflb.ashx
6. Shanbhag AS., 2006. Use of bisphosphonates to improve the durability of total joint replacements. J Am Acad Orthop Surg 14: 215-225.
7. von Knoch F, Eckhardt C, Alabre CI, et al. 2007. Anabolic effects of bisphosphonates on peri-implant bone stock. Biomaterials 28: 3549-3559.
8. Thillemann TM, Pedersen AB, Mehnert F, et al. 2010. Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study. Bone 46: 946-951.
9. HPSC. 2011. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20536 high-risk individuals: a randomised controlled trial. Lancet 10: 2013-2020.
10. Lazzerini PE, Capecchi PL, Selvi E, et al. 2011. Statins and the joint: multiple targets for a global protection ? Semin Arthritis Rheum 40: 430-446.
11. Laing AJ, Dillon JP, Mulhall KJ, et al. 2008. Statins attenuate polymethylmethacrylate-mediated monocyte activation. Acta Orthop 79: 134-140.
12. von Knoch F, Heckelei A, Wedemeyer C, et al. 2005. The effect of simvastatin on polyethylene particle-induced osteolysis. Biomaterials 26: 3549-3555.
13. Yin H, Li J, Yu X, et al. 2011. Effects of simvastatin on osseointegration in a canine total hip arthroplasty model: an experimental study. J Arthroplasty 26: 1534-1539.
14. Thillemann TM, Pedersen AB, Mehnert F, et al. 2010. The risk of revision after primary total hip arthroplasty among statin users: a nationwide population-based nested case-control study. J Bone Joint Surg Am 92: 1063-1072.
15. Rothman KJ, Greenland S, Lash T., 2008. Modern epidemiology, 3rd ed. Philadelphia: Wolters Kluwer, Lippincott, Williams & Wilkins.
16. Zahiri CA, Schmalzried TP, Szuszczewicz ES, et al. 1998. Assessing activity in joint replacement patients. J Arthroplasty 13: 890-895.
17. Beaule PE, Dorey FJ, Hoke R, et al. 2006. The value of patient activity level in the outcome of total hip arthroplasty. J Arthroplasty 21: 547-552.
18. Naal FD, Impellizzeri FM, Leunig M., 2008. Which is the best activity rating scale for patients undergoing total joint arthroplasty ? Clin Orthop Relat Res 467: 958-965.
19. Harris WH., 1969. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 51: 737-755.
20. Ware J Jr, Kosinski M, Keller SD., 1996. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34: 220-233.
21. Clohisy JC, Harris WH., 1999. Primary hybrid total hip replacement, performed with insertion of the acetabular component without cement and a precoat femoral component with cement. An average ten-year follow-up study. J Bone Joint Surg Am 81: 247-255.
22. Mulroy WF, Estok DM, Harris WH., 1995. Total hip arthroplasty with use of so-called second-generation cementing techniques. A fifteen-year-average follow-up study. J Bone Joint Surg Am 77: 1845-1852.
23. Gruen TA, McNeice GM, Amstutz HC., 1979. " Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res 141: 17-27.
24. Barrack RL, Mulroy RD Jr, Harris WH., 1992. Improved cementing techniques and femoral component loosening in young patients with hip arthroplasty. A 12-year radiographic review. J Bone Joint Surg Br 74: 385-389.
25. Landis JR, Koch GG., 1977. The measurement of observer agreement for categorical data. Biometrics 33: 159-174.
26. Engh CA Jr, Sychterz CJ, Young AM, et al. 2002. Interobserver and intraobserver variability in radiographic assessment of osteolysis. J Arthroplasty 17: 752-759.
27. Berry DJ., 1999. Management of osteolysis around total hip arthroplasty. Orthopedics 22: 805-808.
28. Goodman SB, Ma T, Chiu R, et al. 2006. Effects of orthopaedic wear particles on osteoprogenitor cells. Biomaterials 27: 6096-6101.
29. Garrett IR, Mundy GR., 2002. The role of statins as potential targets for bone formation. Arthritis Res 4: 237-240.
30. Lochner K, Fritsche A, Jonitz A, et al. 2011. The potential role of human osteoblasts for periprosthetic osteolysis. Int J Mol Med 28: 1055-1063.
31. Berli BJ, Ping G, Dick W, et al. 2007. Nonmodular flexible press-fit cup in primary total hip arthroplasty: 15-year followup. Clin Orthop Relat Res 461: 114-121.
32. Gwynne-Jones DP, Garneti N, Wainwright C, et al. 2009. The Morscher Press Fit acetabular component: a nine- to 13-year review. J Bone Joint Surg Br 91: 859-864.
33. Garavaglia G, Lübbeke A, Barea C, et al. 2011. Ten-year results with the Morscher press-fit cup: an uncemented, non-modular, porous-coated cup inserted without screws. Int Orthop 35: 957-963.